Skip to main content
Premium Trial:

Request an Annual Quote

Genset SVP Marc Vasseur Takes Helm As CEO

NEW YORK, May 16-Genset co-founder Marc Vasseur will take the helm of the company as chief executive officer and chair of the board, the company said today.


Vasseur replaces pharma veteran Andre Pernet, 56, who recently resigned after serving less than two years as CEO.


Vasseur, 52, helped found the company in 1989. A molecular biologist by training, he served as the company's director and chief biology officer until July 2000. He left Genset to launch and head up an Institut Pasteur spin-off called Pasteur-Mediavita, returning to the company in March 2002 as senior vice president.


In March, Genset Chief Financial Officer John Varian left the firm for personal reasons.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.